NEW YORK (TheStreet) -- Rite Aid (RAD) has had its price target increased to $7.50, Jefferies said Friday. The firm justified the revision by noting the drugstore chain reported a stronger-than-expected fourth quarter and that it is starting to invest in growth. Jefferies kept a "hold" rating.
Must Read: Warren Buffett's 10 Favorite Growth Stocks
Separately, TheStreet Ratings team rates RITE AID CORP as a Hold with a ratings score of C. TheStreet Ratings Team has this to say about their recommendation:
"We rate RITE AID CORP (RAD) a HOLD. The primary factors that have impacted our rating are mixed ? some indicating strength, some showing weaknesses, with little evidence to justify the expectation of either a positive or negative performance for this stock relative to most other stocks. The company's strengths can be seen in multiple areas, such as its revenue growth, compelling growth in net income and solid stock price performance. However, as a counter to these strengths, we also find weaknesses including poor profit margins and weak operating cash flow."
- You can view the full analysis from the report here: RAD Ratings Report